| EFNA4 |
EFNA4, EPLG4, LERK4: Ephrin-A4 precursor |
EPHA4 |
EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor |
15.200 |
Evidence |
|
| EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
EFNA3 |
EFNA3, EFL2, EPLG3, LERK3: Ephrin-A3 precursor |
15.200 |
Evidence |
O
|
| EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
EFNA5 |
EFNA5, EPLG7, LERK7: Ephrin-A5 precursor |
15.200 |
Evidence |
O
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
15.080 |
Evidence |
O
|
| BRCA2 |
BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein |
RAD51 |
RAD51, RAD51A, RECA: DNA repair protein RAD51 homolog 1 |
15.050 |
Evidence |
|
| STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
NMI |
NMI: N-myc-interactor |
14.960 |
Evidence |
O
|
| MRE11A |
MRE11A, HNGS1, MRE11: Double-strand break repair protein MRE11A |
RAD50 |
RAD50: DNA repair protein RAD50 |
14.950 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
CRKL |
CRKL: Crk-like protein |
14.690 |
Evidence |
O
|
| CCND1 |
CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 |
CDKN1B |
CDKN1B, KIP1: Cyclin-dependent kinase inhibitor 1B |
13.510 |
Evidence |
O
|
| BLM |
BLM, RECQ2, RECQL3: Bloom syndrome protein |
RAD51 |
RAD51, RAD51A, RECA: DNA repair protein RAD51 homolog 1 |
13.490 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
DOK1 |
DOK1: Docking protein 1 |
13.490 |
Evidence |
|
| CDC2 |
CDC2: Cell division control protein 2 homolog |
CCNB1 |
Cyclin B1 |
13.490 |
Evidence |
O
|
| CDK4 |
CDK4: Cell division protein kinase 4 |
CDKN1A |
CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1: Cyclin-dependent kinase inhi |
13.360 |
Evidence |
O
|
| EFNA3 |
EFNA3, EFL2, EPLG3, LERK3: Ephrin-A3 precursor |
EPHA7 |
EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor |
13.270 |
Evidence |
|
| CCND1 |
CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
13.2 |
Evidence |
O
|
| JUN |
JUN: Transcription factor AP-1 |
MAPK8 |
MAPK8, JNK1, PRKM8: Mitogen-activated protein kinase 8 |
13.010 |
Evidence |
|
| HDAC3 |
HDAC3: Histone deacetylase 3 |
NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
12.630 |
Evidence |
|
| CTNNB1 |
CTNNB1, CTNNB, OK/SW-cl.35, PRO2286: Catenin beta-1 |
PSEN1 |
PSEN1, AD3, PS1, PSNL1: Presenilin-1 |
11.660 |
Evidence |
|
| FOXO3A |
FOXO3A, FKHRL1: Forkhead box protein O3A |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
11.630 |
Evidence |
O
|
| HTATIP |
HTATIP, TIP60: Histone acetyltransferase HTATIP |
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
11.570 |
Evidence |
|
| SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
NUP214 |
IPI00643352 |
11.5 |
Evidence |
|
| PAX5 |
PAX5: Paired box protein Pax-5 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
11.480 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
IRS1 |
IRS1: Insulin receptor substrate 1 |
11.280 |
Evidence |
|
| SOS1 |
SOS1: Son of sevenless homolog 1 |
GAB1 |
GAB1: GRB2-associated-binding protein 1 |
11.230 |
Evidence |
|
| HGS |
HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate |
TSG101 |
TSG101: Tumor susceptibility gene 101 protein |
10.840 |
Evidence |
|
